How were Exantas Capital's earnings last quarter?

Exantas Capital Corp. (NYSE:XAN) released its quarterly earnings results on Wednesday, November, 4th. The company reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.24 by $0.27. Exantas Capital had a negative net margin of 347.93% and a positive trailing twelve-month return on equity of 8.10%. Read the conference call transcript .

Is Exantas Capital a good dividend stock?

Exantas Capital (NYSE:XAN) pays an annual dividend of $3.30 per share and currently has a dividend yield of 21.15%. XAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 330.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, XAN will have a dividend payout ratio of 2,538.46% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for XAN .

When did Exantas Capital's stock split?

Exantas Capital's stock reverse split on Tuesday, February 16th 2021. The 1-3 reverse split was announced on Thursday, February 4th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 15th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What is Bill Alexander's approval rating as Exantas Capital's CEO?

4 employees have rated Exantas Capital Chief Executive Officer Bill Alexander on Glassdoor.com . Bill Alexander has an approval rating of 82% among the company's employees. 85.0% of employees surveyed would recommend working at Exantas Capital to a friend.

What other stocks do shareholders of Exantas Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include EnLink Midstream (ENLC) , Golar LNG Partners (GMLP) , New Residential Investment (NRZ) , New York Mortgage Trust (NYMT) , Two Harbors Investment (TWO) , Washington Prime Group (WPG) , ADMA Biologics (ADMA) , Hallador Energy (HNRG) , Redwood Trust (RWT) and Zosano Pharma (ZSAN) .

NYSE:XAN

Exantas Capital (XAN) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free XAN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $13.59
▼
$13.94
50-Day Range: $4.34
▼
$16.15
52-Week Range: $2.85
▼
$37.53

Volume: 24,627 shs
Average Volume: 205,768 shs
Market Capitalization: $438.39 million

P/E Ratio: N/A
Dividend Yield: 24.16%
Price Target: N/A

Stock Analysis Competitors Social Media

Get Exantas Capital alerts:

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About Exantas Capital Stock (NYSE:XAN)

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

XAN Stock News Headlines

February 3, 2024 | cnet.com

Capital One CD Rates for January 2024

November 7, 2023 | investopedia.com

Capital One Savings Account Interest Rates: November 2023

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

June 12, 2023 | msn.com

ACRES Commercial: Preferreds For Yield, Common For Upside

March 30, 2023 | investopedia.com

Tier 1 Capital: Definition, Components, Ratio, and How It's Used

March 1, 2023 | markets.businessinsider.com

Here's what Wall Street expects from Exantas Capital's earnings

August 1, 2022 | apnews.com

CRE Industry Veteran Eric T. Baum Joins Greystone Monticello

July 7, 2022 | es.investing.com

NN Inc (NNBR)

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 30, 2022 | investing.com

XAN_pc_old Historical Data

February 4, 2022 | fool.com

ACRES Commercial Realty Corp(ACR)

January 6, 2022 | investing.com

ACRES Commercial Realty Pref Series D (ACR_pd)

November 3, 2021 | markets.businessinsider.com

Here's what to expect from Exantas Capital's earnings report

July 24, 2021 | barrons.com

ACRES Commercial Realty Corp. 7.875% Pfd. Series D

See More Headlines

Receive XAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exantas Capital and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2020
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Finance
Industry: Real Estate Investment Trusts
Sub-Industry: N/A
Current Symbol: NYSE:XAN
CUSIP: N/A
CIK: N/A
Web: www.exantas.com
Phone: 516-535-0015
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $1.00
Trailing P/E Ratio: N/A
Forward P/E Ratio: 25.74
P/E Growth: N/A
Net Income: $35.97 million
Net Margins: -347.93%
Pretax Margin: N/A
Return on Equity: 8.10%
Return on Assets: 1.61%

Debt

Debt-to-Equity Ratio: 5.01
Current Ratio: 251.90
Quick Ratio: 251.90

Sales & Book Value

Annual Sales: $61.15 million
Price / Sales: 7.16
Cash Flow: $10.18 per share
Price / Cash Flow: 1.34
Book Value: $17.45 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 32,093,000
Free Float: N/A
Market Cap: $437.75 million
Optionable: Not Optionable
Beta: 1.32

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. David J. Bryant (Age 63)
Sr. VP, CFO & Treasurer
Comp: $660.85k
Mr. Thomas C. Elliott (Age 48)
Exec. VP of Fin. & Operations
Comp: $349.43k
Mr. Eldron C. Blackwell (Age 42)
VP & Chief Accounting Officer
Comp: $297.92k
Mr. Mark Steven Fogel
Pres, CEO & Director
Mr. Steven Landgraber
Sr. VP of Corp. Fin. & Investor Relations Officer
Ms. Michele R. Weisbaum (Age 60)
Chief Legal Officer, Sr. VP & Sec.
Mr. Alan Frank Feldman (Age 57)
Sr. VP of Real Estate Investments
Mr. David E. Bloom J.D. (Age 56)
Sr. VP - Real Estate Investments
Mr. Jeffrey Dean Blomstrom (Age 52)
Sr. VP
Mr. Kyle Geoghegan (Age 52)
Sr. VP of Loan Originations

Key Competitors

View All Competitors

XAN Stock Analysis - Frequently Asked Questions

How were Exantas Capital's earnings last quarter?: Exantas Capital Corp. (NYSE:XAN) released its quarterly earnings results on Wednesday, November, 4th. The company reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.24 by $0.27. Exantas Capital had a negative net margin of 347.93% and a positive trailing twelve-month return on equity of 8.10%.
Read the conference call transcript.
Is Exantas Capital a good dividend stock?: Exantas Capital (NYSE:XAN) pays an annual dividend of $3.30 per share and currently has a dividend yield of 21.15%. XAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 330.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, XAN will have a dividend payout ratio of 2,538.46% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for XAN.
When did Exantas Capital's stock split?: Exantas Capital's stock reverse split on Tuesday, February 16th 2021. The 1-3 reverse split was announced on Thursday, February 4th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 15th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What is Bill Alexander's approval rating as Exantas Capital's CEO?: 4 employees have rated Exantas Capital Chief Executive Officer Bill Alexander on Glassdoor.com. Bill Alexander has an approval rating of 82% among the company's employees. 85.0% of employees surveyed would recommend working at Exantas Capital to a friend.
What other stocks do shareholders of Exantas Capital own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include EnLink Midstream (ENLC), Golar LNG Partners (GMLP), New Residential Investment (NRZ), New York Mortgage Trust (NYMT), Two Harbors Investment (TWO), Washington Prime Group (WPG), ADMA Biologics (ADMA), Hallador Energy (HNRG), Redwood Trust (RWT) and Zosano Pharma (ZSAN).

This page (NYSE:XAN) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Exantas Capital (XAN) Stock Price, News & Analysis

About Exantas Capital Stock (NYSE:XAN)

XAN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

XAN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info